Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Visualizing the course of antigen-specific CD8 and CD4 T cell responses to a growing tumor.

Klein L, Trautman L, Psarras S, Schnell S, Siermann A, Liblau R, von Boehmer H, Khazaie K.

Eur J Immunol. 2003 Mar;33(3):806-14.

2.

Stabilization of beta-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia.

Gounari F, Signoretti S, Bronson R, Klein L, Sellers WR, Kum J, Siermann A, Taketo MM, von Boehmer H, Khazaie K.

Oncogene. 2002 Jun 13;21(26):4099-107.

3.

The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.

Dihlmann S, Siermann A, von Knebel Doeberitz M.

Oncogene. 2001 Feb 1;20(5):645-53.

4.

Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression.

Koesters R, Adams V, Betts D, Moos R, Schmid M, Siermann A, Hassam S, Weitz S, Lichter P, Heitz PU, von Knebel Doeberitz M, Briner J.

Genomics. 1999 Oct 15;61(2):210-8.

PMID:
10534406
5.

Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.

Dihlmann S, Gebert J, Siermann A, Herfarth C, von Knebel Doeberitz M.

Cancer Res. 1999 Apr 15;59(8):1857-60.

6.

Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.

Würl P, Taubert H, Bache M, Kroll J, Meye A, Berger D, Siermann A, Holzhausen HJ, Hinze R, Schmidt H, Rath FW.

Int J Cancer. 1996 Aug 22;69(4):317-23.

7.

[Toxic shock syndrome in a 6-year-old male].

Siermann A, Storm W.

Monatsschr Kinderheilkd. 1991 Apr;139(4):231-4. German.

PMID:
2072965

Supplemental Content

Loading ...
Support Center